insights_auto
Why is EDIT down 13.82%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
$1.87
arrow_downward
-13.82%(-0.30) 1D
$1.91
arrow_upward
+2.14% (+0.040)bedtimeAfter hours
Closed: Nov 16, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.10
High
$2.12
Low
$1.86
Mkt. cap
288.62M
Avg. vol.
2.44M
Volume
0.00
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
Open
$2.10
High
$2.12
Low
$1.86
Mkt. cap
288.62M
Avg. vol.
2.44M
Volume
0.00
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
News stories
From web sources and news partners
Benzinga
·
51 minutes ago
Stock Market: Will S&P 500 Open Up or Down Today?
The Motley Fool
·
15 hours ago
Is an Equal-Weight S&P 500 Fund Safer Right Now Than the One You Own?
ChartMill
·
13 hours ago
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
Traders Union
·
8 hours ago
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com